Standard BioTools Files 8-K: Regulation FD & Exhibits

Ticker: LAB · Form: 8-K · Filed: Sep 5, 2024 · CIK: 1162194

Standard Biotools Inc. 8-K Filing Summary
FieldDetail
CompanyStandard Biotools Inc. (LAB)
Form Type8-K
Filed DateSep 5, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

Standard BioTools filed an 8-K on Sept 5th covering Reg FD and exhibits. Formerly Fluidigm.

AI Summary

On September 5, 2024, Standard BioTools Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Fluidigm Corp, is incorporated in Delaware and headquartered in South San Francisco, California.

Why It Matters

This 8-K filing provides important updates regarding regulatory disclosures and financial exhibits for Standard BioTools Inc., which may impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material adverse events.

Key Players & Entities

  • Standard BioTools Inc. (company) — Registrant
  • September 5, 2024 (date) — Date of report
  • Fluidigm Corp (company) — Former company name
  • Delaware (jurisdiction) — State of Incorporation
  • South San Francisco, California (location) — Principal Executive Offices

FAQ

What specific information is being disclosed under Regulation FD in this 8-K filing?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.

What types of financial statements and exhibits are included with this 8-K filing?

The filing states 'Financial Statements and Exhibits' are included, but the specific nature of these documents is not detailed in the provided text.

When was Standard BioTools Inc. formerly known as Fluidigm Corp?

The date of the name change from Fluidigm Corp to Standard BioTools Inc. was November 13, 2001.

What is the principal business address of Standard BioTools Inc.?

The principal executive offices are located at 2 Tower Place, Suite 2000, South San Francisco, California 94080.

What is the IRS Employer Identification Number for Standard BioTools Inc.?

The IRS Employer Identification Number for Standard BioTools Inc. is 77-0513190.

Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-09-05 16:07:26

Key Financial Figures

  • $0.001 — ch registered Common stock, par value $0.001 per share LAB Nasdaq Global Select Ma

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 5, 2024, Standard BioTools Inc. (the "Company") updated its investor presentation, which the Company expects to use in connection with general corporate presentations and will be made available on the Company's website or distributed by the Company in hardcopy or electronic form. The investor presentation is attached hereto as Exhibit 99.1 and incorporated herein by reference. The investor presentation is current as of September 5, 2024, and the Company disclaims any obligation to update the investor presentation after such date. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d)Exhibits. Exhibit No. Description 99.1 Investor Presentation issued by Standard BioTools Inc., dated September 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2024 STANDARD BIOTOOLS INC. By: /s/ Michael Egholm, Ph.D. Name: Michael Egholm, Ph.D. Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.